Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History IMRN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics IMRN

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Immuron Ltd ADR

IMRN
Current price
1.73 USD -0.03 USD (-1.70%)
Last closed 1.78 USD
ISIN US45254U1016
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 10 168 336 USD
Yield for 12 month -17.81 %
1Y
3Y
5Y
10Y
15Y
IMRN
21.11.2021 - 28.11.2021

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. It also develops Travelan (IMM-124E), which is in Phase II clinical trial, to reduce the risk of contracting travelers' diarrhea; and IMM-529, which is in Phase II clinical trial, for treating patients suffering from recurring clostridium difficile infection. The company has a collaboration with the US Naval Medical Research Command and Silver Spring, MD, USA to develop and clinically evaluate a therapeutic targeting Campylobacter and enterotoxigenic Escherichia coli infections; and a research collaboration with the Walter Reed Army Institute of Research to develop three Shigella-specific therapeutic products. The company was formerly known as Anadis Limited and changed its name to Immuron Limited in December 2008. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia. Address: 62 Lygon Street, Carlton, VIC, Australia, 3053

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

4.83 USD

P/E Ratio

Dividend Yield

Financials IMRN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures IMRN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+3 211 845 USD

Last Year

+1 182 254 USD

Current Quarter

+1 308 338 USD

Last Quarter

+1 308 338 USD

Current Year

+2 185 921 USD

Last Year

+857 616 USD

Current Quarter

+870 311 USD

Last Quarter

+870 311 USD
EBITDA -5 729 396 USD
Operating Margin TTM -63.56 %
Price to Earnings
Return On Assets TTM -22.36 %
PEG Ratio
Return On Equity TTM -52.77 %
Wall Street Target Price 4.83 USD
Revenue TTM 6 541 626 USD
Book Value 0.045 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 69.60 %
Dividend Yield
Gross Profit TTM 4 413 498 USD
Earnings per share -0.85 USD
Diluted Eps TTM -0.85 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY
Profit Margin -112.40 %

Stock Valuation IMRN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.49
Price Sales TTM 1.55
Enterprise Value EBITDA 0.77
Price Book MRQ 1.49

Technical Indicators IMRN

For 52 Weeks

1.50 USD 2.87 USD
50 Day MA 1.80 USD
Shares Short Prior Month 20 682
200 Day MA 1.96 USD
Short Ratio 0.52
Shares Short 24 504
Short Percent 0.65 %